Cargando…
Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway
Rationale: Malignant ascites caused by cancer cells results in poor prognosis and short average survival time. No effective treatment is currently available for malignant ascites. In this study, the effects of lentinan (LNT)-functionalized selenium nanoparticles (Selene) on malignant ascites were ev...
Autores principales: | Liu, Hui-Juan, Qin, Yuan, Zhao, Zi-Han, Zhang, Yang, Yang, Jia-Huan, Zhai, Deng-Hui, Cui, Fang, Luo, Ce, Lu, Man-Xi, Liu, Piao-Piao, Xu, Heng-Wei, Li, Kun, Sun, Bo, Chen, Shuang, Zhou, Hong-Gang, Yang, Cheng, Sun, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415812/ https://www.ncbi.nlm.nih.gov/pubmed/32802180 http://dx.doi.org/10.7150/thno.46467 |
Ejemplares similares
-
Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum
por: Liu, Hui-Juan, et al.
Publicado: (2022) -
The MFN1 and MFN2 mitofusins promote clustering between mitochondria and peroxisomes
por: Huo, Yinbo, et al.
Publicado: (2022) -
Mitigation of Acetamiprid Residue Disruption on Pea Seed Germination by Selenium Nanoparticles and Lentinans
por: Lin, Yongxi, et al.
Publicado: (2023) -
Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI
por: Liu, Guanfu, et al.
Publicado: (2022) -
Therapeutic effects of lentinan on inflammatory bowel disease and colitis‐associated cancer
por: Liu, Yanrong, et al.
Publicado: (2018)